Renal denervation in 2025: long-term evidence supporting sympathetic modulation as a durable strategy for uncontrolled hypertension
Background: Renal denervation (RDN) has emerged as a promising device-based therapy for uncontrolled hypertension. Recent data from major cardiovascular conferences (EuroPCR, ESH, TCT 2025) provide unprecedented 3-year follow-up evidence on efficacy, safety, and clinical outcomes. Methods: We synthe...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2026-06-01
|
| Col·lecció: | International Journal of Cardiology. Cardiovascular Risk and Prevention |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2772487526000176 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|